fbpx

New Look Vision Reports Strong Record Results for Q3 of Fiscal 2020

New Look Vision Group reported financial results today for the 13 and 39 week periods ended September 26, 2020 (“Q3 2020”) and provided updates on actions in response to COVID-19, store re-openings, and new financing arrangements.

Q3 2020 Financial and Operational Highlights

• Revenues increased significantly by 16.8% to $86.9 million year-over-year driven primarily by comparable store sales growth as well as from newly acquired stores, offset by revenue from scheduled store closures and from COVID-19 headwinds.

• Comparable store sales were up 13.5% as a result of Q2 closure pent up demand and enhanced store operating procedures.

• Adjusted EBITDA attributed to shareholders was $34.7 million, increasing by $20.3 million or 140.8% from last year and increased 141.3% on a per diluted share basis to $2.22.

• The Company actively continued to pursue its significant pipeline of acquisition opportunities in Canada and the United States.

Actions in response to COVID-19

COVID-19 has drastically altered the way optical retailers operate on both brick and mortar and ecommerce levels. As consumers increasingly move online, New Look Vision’s investments in omnichannel experience and anticipation of the evolving consumer journey complements and enhances their physical retail presence. This approach increases accessibility to differentiated, customized and precise eye care, while ensuring safety for consumers across Canada. Our central lens processing facility pivoted to begin producing safety eyewear for use in health care facilities.

Phased Network Re-Opening Complete

Gradual store re-openings started on May 4th in line with local and professional regulations, with all of New Look Vision’s entire store network open for business by the end of the second quarter. In advance of reopening its stores, the Company issued stringent health and safety procedures, undertook extensive training in the form of in-store rehearsals and is providing each location with prescribed personal protection equipment.

President & CEO’s comments

Antoine Amiel, the President and CEO of New Look Vision, stated that: “New Look Vision overcame ongoing market headwinds to deliver an exceptional set of third quarter results, largely driven by the phased reopening of our stores from mid-May as restrictions lifted. Revenues and comparable store sales rose 16.8% and 13.5% year-over-year respectively, which in combination with careful cost management are driving positive momentum, highlighted by EBITDA doubling year-over-year. Additionally, net debt decreased by $22.5 million compared to Q2. Complementary to our physical locations, our newly launched websites and iPhone applications deliver customer convenience and diversifies our revenue streams as part of our omnichannel strategy. Additionally, we continue to actively pursue our significant pipeline of acquisition opportunities in Canada and the United States. While ongoing mandated restrictive measures and their potential impacts on New Look Vision’s performance are difficult to predict, we’re looking to the future with an optimistic outlook, driven by the resiliency of our high quality, essential, eye care and eyewear products and services as well as our ability to evolve ahead of market trends to drive long-term shareholder value.”

Click HERE for the full press release.

Diabetes Awareness Month Helps Highlight Importance of Regular Eye Care

One of the leading causes of blindness among Canadians is diabetic retinopathy, which affects as many as 749,800 people, yet early detection and treatment can reduce the risk of blindness by 95%, according to the Canadian Ophthalmological Society. To spread awareness during Diabetes Awareness Month, the Canadian Ophthalmological Society and Diabetes Canada have partnered to highlight the importance of regular eye care for preventing vision loss among the approximately 11.5 million Canadians who are currently living with diabetes or prediabetes.

“Being diagnosed with any disease already comes with its own host of challenges, let alone losing your eyesight, which can dramatically affect independence and quality of life,” says Dr. Colin Mann, President of the Canadian Ophthalmological Society. “The odds of getting a serious eye disease are higher than you think and, for adults with diabetes in particular, regular eye exams at least once a year are a critical part of complete diabetes care and management.”

The theme of Diabetes Canada’s Diabetes Awareness Month campaign is “Let’s End Diabetes Together” and, during the month of November, will shine a light on the challenges and triumphs of those affected by the disease.

“The driving force behind our annual campaign is to advocate for and bring greater awareness of diabetes, its risk factors and misconceptions,” said Laura Syron, president and CEO of Diabetes Canada. “Now more than ever, we need to awaken the world to the epidemic that diabetes has become.”

Click HERE for the full press release.

“Gabe” Sunglass Featuring Eagle Artwork by Ts’msyen and Cree Nations Artist Phil Gray

With an acetate top and shiny metallic rims below, Gabe has a club master vibe but in a refreshed contemporary way. This unisex frame combines polished accents of silver or gold seamlessly with a hand-made acetate and adjustable nose pads.

Inner temples highlight the artist name in engraved gold detail. Gabe sunglasses feature a Striking eagle design by Phil Gray.

Distributed by: www.claudiaalan.com

Novel Eye Drop to Relieve Presbyopia Enters Phase 3 Clinicals

Orasis Pharmaceuticals, an Israeli based  ophthalmic pharmaceutical company announced the start of Phase 3 clinical studies in the US to evaluate novel eye drop candidate, CSF-1, designed to provide temporary correction of presbyopia.

The proprietary eye drop exerts its pharmacological action through pupil modulation. In clinical trials, the medication was dosed twice daily allowing patients to choose how and when to use it.

According to information provided by the company, the eye drop candidate is a proprietary combination of low-dose pilocarpine combined with multi-faceted vehicles designed to achieve the optimal balance between efficacy, safety and comfort.

The ophthalmological use of pilocarpine is well known. The side effect profile of pilocarpine includes eye irritation, temporary blurred vision, poor vision in low light, and headache or brow ache.

The company told Optik, “Clinical trials to date have demonstrated CSF-1 being a well-tolerated formulation with only mild and temporary adverse events.” 

Further, a Phase 2 study completed at the end of 2019 showed no impact on distance or night vision, according to the company. 

The Phase 3 studies are multi-centre, double-masked, parallel-group clinical trials in the US enrolling approximately 600 participants with presbyopia to further evaluate the efficacy and safety of CSF-1.

Upon completion of these studies and FDA approval the company will explore launches in additional countries. No specific plans for commercialization in Canada were provided upon request. 

One day, patients may opt to preemptively instil an eye drop instead of fumbling to find readers to view the fine print on a menu.

About Orasis Pharmaceuticals
Orasis is an emerging ophthalmic pharmaceutical company committed to making near vision clear again for people with presbyopia. Orasis’ novel proprietary formulation, designed to achieve an optimal balance between efficacy, safety and comfort, has the potential to position the company as an emerging leader in the presbyopia space. Orasis is based in Herzliya, Israel. For more information, visit https://www.orasis-pharma.com 

Quebec’s OPTOPLUS Banner Reinvents Annual Les journées OPTOPLUS Gathering

More than 200 OPTOPLUS eye care clinic owners and employees, as well as supplier partners and sponsors, gathered virtually on Sunday, October 25th, as the banner presented their innovative online conference.

“These past few months have been filled with uncertainty and our industry has had to face many challenges. This is why today, more than ever, we are committed to offering support to our members, especially in the development of technology and e-Commerce. Moreover, the OPTOPLUS banner clinics set themselves apart through their efficient use of technological tools,” said Patrice Lacoste, President and CEO of OSI Group.

With a focus on improving and optimizing clinic operations, participants benefited from the advice and expertise of three renowned speakers:

– An expert in her field and a seasoned entrepreneur, Isabelle Huot, PhD in Nutrition and columnist for TVA and the Journal de Montréal shared her recipe for success with the audience.

– Change is permanent – there is no better time than now to broach this subject! Speaker and author Sylvain Guimond, D.O. PhD presented an inspiring approach to better adapt to change and how to harness it through creativity and commitment.

-During her presentation of “The Art of Being a Good Buyer,” Stéphanie Byette, licensed optician, college-level teacher in visual orthotics and consultant for Mood Eyewear, presented her golden rules on how to become a top-notch frame buyer.

The virtual event also featured interactive games, clips from Safilo and Marcolin on the upcoming frame trends for 2021 as well as entertaining musical sets by DJ Lady Blackice.

Click HERE for the full press release.

Featured Posts

Transitions Optical logo 2024 noir

See the Rockies in a New Light: Transitions® Launches Panoramic Train Adventure Contest

Transitions has launched a national consumer contest running from May 1 to December 31, 2026, offering one winner a luxury panoramic train journey through the Canadian Rockies.

Learn More
Marchon Nike Vision campaign May 2026

Nike Vision Launches First Football-Focused Brand Campaign

Nike Vision has launched its first football-focused brand campaign, highlighting the Zeus Rise and Radeon eyewear styles ahead of this summer’s major tournaments.

Read more
Optik Voila May-June 2026 COS Silhouette 4572_7010

Titanium Reframed: Silhouette’s Bold New Chapter

Silhouette’s Titanium Reframed collection brings a bold new perspective to ultralight eyewear, with full-rim frames laser-cut from ultra-thin titanium and finished in modern matte metallic shades.

Read more
Lumenis OptiLIFT image and logo May 2026

Lumenis OptiLIFT Receives Health Canada Approval for Evaporative Dry Eye Use

Health Canada has authorized Lumenis OptiLIFT for evaporative dry eye disease, lower lid laxity and blink function improvement.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Podcast: Episode 11 Explores Succession Planning, Resilience, and Leadership with Dr. Diana Monea

Episode 11 of Eye on the Industry features Dr. Diana Monea on succession planning, resilience, leadership, and rebuilding after major life transitions in optometry.

Read more
Transitions Optical logo 2024 noir

See the Rockies in a New Light: Transitions® Launches Panoramic Train Adventure Contest

Transitions has launched a national consumer contest running from May 1 to December 31, 2026, offering one winner a luxury panoramic train journey through the Canadian Rockies.

Learn More
Marchon Nike Vision campaign May 2026

Nike Vision Launches First Football-Focused Brand Campaign

Nike Vision has launched its first football-focused brand campaign, highlighting the Zeus Rise and Radeon eyewear styles ahead of this summer’s major tournaments.

Read More
Optik Voila May-June 2026 COS Silhouette 4572_7010

Titanium Reframed: Silhouette’s Bold New Chapter

Silhouette’s Titanium Reframed collection brings a bold new perspective to ultralight eyewear, with full-rim frames laser-cut from ultra-thin titanium and finished in modern matte metallic shades.

Read More
Lumenis OptiLIFT image and logo May 2026

Lumenis OptiLIFT Receives Health Canada Approval for Evaporative Dry Eye Use

Health Canada has authorized Lumenis OptiLIFT for evaporative dry eye disease, lower lid laxity and blink function improvement.

Read More
Eye On the Industry podcast EOTI

Eye on the Industry Podcast: Episode 11 Explores Succession Planning, Resilience, and Leadership with Dr. Diana Monea

Episode 11 of Eye on the Industry features Dr. Diana Monea on succession planning, resilience, leadership, and rebuilding after major life transitions in optometry.

Read More
Transitions Optical logo 2024 noir

See the Rockies in a New Light: Transitions® Launches Panoramic Train Adventure Contest

Transitions has launched a national consumer contest running from May 1 to December 31, 2026, offering one winner a luxury panoramic train journey through the Canadian Rockies.

Learn More
Marchon Nike Vision campaign May 2026

Nike Vision Launches First Football-Focused Brand Campaign

Nike Vision has launched its first football-focused brand campaign, highlighting the Zeus Rise and Radeon eyewear styles ahead of this summer’s major tournaments.

Read more
Optik Voila May-June 2026 COS Silhouette 4572_7010

Titanium Reframed: Silhouette’s Bold New Chapter

Silhouette’s Titanium Reframed collection brings a bold new perspective to ultralight eyewear, with full-rim frames laser-cut from ultra-thin titanium and finished in modern matte metallic shades.

Read more
Lumenis OptiLIFT image and logo May 2026

Lumenis OptiLIFT Receives Health Canada Approval for Evaporative Dry Eye Use

Health Canada has authorized Lumenis OptiLIFT for evaporative dry eye disease, lower lid laxity and blink function improvement.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Podcast: Episode 11 Explores Succession Planning, Resilience, and Leadership with Dr. Diana Monea

Episode 11 of Eye on the Industry features Dr. Diana Monea on succession planning, resilience, leadership, and rebuilding after major life transitions in optometry.

Read more
Transitions Optical logo 2024 noir

See the Rockies in a New Light: Transitions® Launches Panoramic Train Adventure Contest

Transitions has launched a national consumer contest running from May 1 to December 31, 2026, offering one winner a luxury panoramic train journey through the Canadian Rockies.

Learn More
Marchon Nike Vision campaign May 2026

Nike Vision Launches First Football-Focused Brand Campaign

Nike Vision has launched its first football-focused brand campaign, highlighting the Zeus Rise and Radeon eyewear styles ahead of this summer’s major tournaments.

Read more
Optik Voila May-June 2026 COS Silhouette 4572_7010

Titanium Reframed: Silhouette’s Bold New Chapter

Silhouette’s Titanium Reframed collection brings a bold new perspective to ultralight eyewear, with full-rim frames laser-cut from ultra-thin titanium and finished in modern matte metallic shades.

Read more
Lumenis OptiLIFT image and logo May 2026

Lumenis OptiLIFT Receives Health Canada Approval for Evaporative Dry Eye Use

Health Canada has authorized Lumenis OptiLIFT for evaporative dry eye disease, lower lid laxity and blink function improvement.

Read more
Eye On the Industry podcast EOTI

Eye on the Industry Podcast: Episode 11 Explores Succession Planning, Resilience, and Leadership with Dr. Diana Monea

Episode 11 of Eye on the Industry features Dr. Diana Monea on succession planning, resilience, leadership, and rebuilding after major life transitions in optometry.

Read more